Hooman Soleymani majd

Honorary Senior Clinical lecturer, Oxford University, Consultant Gynaecological oncology surgeon at oxford university hospitals NHS foundation Trust.

[Hooman Soleymani majd @SmHooman]

Preliminary study on the intraoperative application of the “dual-path” strategy for sentinel lymph node tracing in endometrial cancer | Scientific Reports https://t.co/phVZCWb6hT

[Nuffield Department of Surgical Sciences @NDSurgicalSci]

🚨 NEW VIDEO 🚨

Mr. Hooman Soleymani majd discusses 'The Evolving Role of Gynaecological Oncology Surgeons Beyond Gynaecological Malignancies in the Modern Era'.

Watch now ➡️ https://t.co/UO5HmYZqXX

[Hooman Soleymani majd @SmHooman]

https://t.co/mpaYuouy4A

[Hooman Soleymani majd @SmHooman]

Acute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report - More - 2026 - Clinical Case Reports - Wiley Online Library https://t.co/V09989HPLN

[Hooman Soleymani majd @SmHooman]

https://t.co/nTR1WvRJee

[Hooman Soleymani majd @SmHooman]

Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort study https://t.co/NYuRQwUs6o

[Sally Collins @AccretaResearch]

Delighted to report that our paper on the long-term safety of surgical devascularisation for placenta accreta spectrum has been published today.

This technique is easier than obstetricians think and is safe and life-saving for catastrophic haemorrhage.

https://t.co/WX8SSLLqDd

[Hooman Soleymani majd @SmHooman]

https://t.co/VkqVq3ybS9

[Hooman Soleymani majd @SmHooman]

The Preoperative Prognosticators of Surgical Margins (R0 vs. R1) in Pelvic Exenteration—A 14-Year Retrospective Study from a Tertiary Referral Centre https://t.co/ts0sWYK9e8 #mdpicancers via @Cancers_MDPI

[Hooman Soleymani majd @SmHooman]

⁦@FrontiersIn⁩ https://t.co/EA8MVBB4A0

[Institute of Academic Surgery @RPA_IAS]

🎉#PelvExSydney2025 is officially wrapping up — and what an incredible few days it’s been!!!🔬
🌏To all our delegates, speakers, moderators, and sponsors: thank you for your energy, insights, and commitment to advancing pelvic exenteration surgery!🙏
🌐 https://t.co/pBm6xgO6TV

[Hooman Soleymani majd @SmHooman]

Speakers — PelvEx https://t.co/Ik5zVerfP9

[Hooman Soleymani majd @SmHooman]

PelvEx ⁦@RPA_IAS⁩ https://t.co/tWWGCoNlJD

[Hooman Soleymani majd @SmHooman]

Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis - American Journal of Obstetrics & Gynecology https://t.co/aZ3YxCt5KM @UniofOxford

[Hooman Soleymani majd @SmHooman]

Association between the age-adjusted visceral adiposity index (AVAI) and gynecologic malignancies: a cross-sectional study based on NHANES data https://t.co/4ylI5ke86i @UniofOxford

[Hooman Soleymani majd @SmHooman]

Clinicopathological Characteristics and Oncologic Outcomes of Endometrioid Ovarian Carcinoma: A Retrospective Study from a Tertiary Cancer Centre https://t.co/ybuDdPe2Cn #mdpibiomedicines via @Biomed_MDPI @OvarianCancerUK @UniofOxford

[Hooman Soleymani majd @SmHooman]

Association between the age-adjusted visceral adiposity index (AVAI) and gynecologic malignancies: a cross-sectional study based on NHANES data - Zhang - Translational Cancer Research ⁦@OvarianCancerUK⁩ ⁦@ESSOnews⁩ ⁦⁦@0XFORDUNI⁩ https://t.co/4ylI5kdAgK

[Hooman Soleymani majd @SmHooman]

BBC Radio Oxford local winners at Make a Difference Awards final - BBC News ⁦@BBCOxford⁩ ⁦@BBCSouthNews⁩ ⁦@OUHospitals⁩ ⁦@TheOxfordMail⁩ https://t.co/P2O08lwDew